COVID-19 VACCINATION PROGRAM INTERIM PLAYBOOK for JURISDICTION OPERATIONS – October 29, 2020

Total Page:16

File Type:pdf, Size:1020Kb

COVID-19 VACCINATION PROGRAM INTERIM PLAYBOOK for JURISDICTION OPERATIONS – October 29, 2020 COVID-19 Vaccination Program Interim Operational Guidance InterimJurisdiction Operational Operations Guidance Centers for Disease Control and Prevention (CDC) October 29, 2020 Version 2.0 COVID-19 VACCINATION PROGRAM INTERIM PLAYBOOK FOR JURISDICTION OPERATIONS – October 29, 2020 Table of Contents Executive Summary ....................................................................................................................................................5 Section 1: Public Health Preparedness Planning ........................................................................................................6 Improvement Planning .......................................................................................................................................6 COVID-19 Vaccination Program Planning ...........................................................................................................6 Section 2: COVID-19 Organizational Structure and Partner Involvement ..................................................................8 Planning and Coordination Team (Internal) .......................................................................................................8 State-Local Coordination ....................................................................................................................................8 Tribal Nations and Tribal Communities ..............................................................................................................9 COVID-19 Vaccination Program Implementation Committee (Internal and External) .......................................9 Related Guidance and Reference Materials .................................................................................................... 10 Section 3: Phased Approach to COVID-19 Vaccination ........................................................................................... 11 Phase 1: Potentially Limited COVID-19 Vaccine Doses Available .................................................................... 12 Phase 2: Large Number of Doses Available; Supply Likely to Meet Demand .................................................. 13 Phase 3: Likely Sufficient Supply ...................................................................................................................... 14 Related Guidance and Reference Materials .................................................................................................... 14 Section 4: Critical Populations ................................................................................................................................. 15 Identifying and Estimating Critical Populations ............................................................................................... 15 Estimating Population Groups for Initial COVID-19 Vaccine Distribution During Phase 1 .............................. 16 Describing and Locating Critical Populations ................................................................................................... 16 Related Guidance and Reference Materials .................................................................................................... 17 Section 5: COVID-19 Vaccination Provider Recruitment and Enrollment ............................................................... 19 Vaccination Provider Recruitment ................................................................................................................... 19 Vaccination Provider Enrollment ..................................................................................................................... 21 COVID-19 Vaccination Provider Training ......................................................................................................... 23 Role of Commercial and Federal Partners ....................................................................................................... 25 Federal Pharmacy Partnership for COVID-19 Vaccination in Long-Term Care Facilities ................................. 26 Federal Direct Allocation to Pharmacy Partners (Phase 2) .............................................................................. 26 Related Guidance and Reference Materials .................................................................................................... 26 Section 6: Understanding a Jurisdiction’s COVID-19 Vaccine Administration Capacity .......................................... 27 Related Guidance and Reference Materials .................................................................................................... 28 Section 7: COVID-19 Vaccine Allocation, Ordering, Distribution, and Inventory Management ............................. 29 2 | Page Version 2.0 COVID-19 VACCINATION PROGRAM INTERIM PLAYBOOK FOR JURISDICTION OPERATIONS – October 29, 2020 Allocation ......................................................................................................................................................... 29 Ordering ........................................................................................................................................................... 29 Distribution ...................................................................................................................................................... 30 Inventory Management ................................................................................................................................... 31 COVID-19 Vaccine Recovery ............................................................................................................................ 32 Section 8: COVID-19 Vaccine Storage and Handling ............................................................................................... 33 Satellite, Temporary, and Off-Site Clinic Storage and Handling Considerations ............................................. 33 Section 9: COVID-19 Vaccine Administration Documentation and Reporting ........................................................ 35 Section 10: COVID-19 Vaccination Second-Dose Reminders .................................................................................. 37 Section 11: COVID-19 Requirements for Immunization Information Systems or Other External Systems ............ 38 System Infrastructure ...................................................................................................................................... 39 COVID-19 Vaccination Provider Preparation ................................................................................................... 39 Data Management ........................................................................................................................................... 39 Ordering and Inventory ................................................................................................................................... 40 Related Guidance and Reference Materials .................................................................................................... 40 Section 12: COVID-19 Vaccination Program Communication ................................................................................. 42 COVID-19 Vaccination Communication Objectives ......................................................................................... 42 Key Audiences .................................................................................................................................................. 42 Broad Communication Planning Phases .......................................................................................................... 42 Communication Activities ................................................................................................................................ 43 Messaging Considerations ............................................................................................................................... 43 Communication Channels ................................................................................................................................ 44 Partners and Trusted Sources .......................................................................................................................... 44 Crisis and Risk Communication ........................................................................................................................ 44 Related Guidance and Reference Materials .................................................................................................... 45 Section 13: Regulatory Considerations for COVID-19 Vaccination ......................................................................... 46 Emergency Use Authorization Fact Sheets ...................................................................................................... 46 Vaccine Information Statements ..................................................................................................................... 46 Section 14: COVID-19 Vaccine Safety Monitoring ................................................................................................... 47 Vaccine Adverse Event Reporting System ....................................................................................................... 47 v-safe ................................................................................................................................................................ 47 Vaccine Safety Datalink ...................................................................................................................................
Recommended publications
  • Water Supply and Sanitation & Integrated Water Resources
    Water Supply and Sanitation & Integrated Water Resources Management: why seek better integration? John Butterworth1 and John Soussan2 1Natural Resources Institute, University of Greenwich, UK 2Centre for Water Policy and Development, University of Leeds, UK WHIRL Project Working Paper 2 Preliminary results of research for discussion and comment Prepared for WHIRL project workshop on ‘Water Supply & Sanitation and Watershed Development: positive and negative interactions’, Andhra Pradesh, India, 5-14 May 2001 This project is supported by the UK Department for International Development (DFID) through the Infrastructure and Urban Development Division’s Knowledge and Research programme. Project R7804 ‘Integrating drinking water needs in watershed projects’ 1 INTRODUCTION This working paper was prepared as a contribution to a joint Indian, South African and UK research project on Water, Households and Rural Livelihoods (WHIRL). The objectives of the paper are to identify approaches to improve access of the poor to secure, safe and sustainable water supplies in areas of water scarcity, and to identify some of the key challenges to the more effective management of water resources in these areas. It is targeted at organisations responsible for the delivery of water supply and sanitation (WSS) services and management of land and water resources in developing countries. It aims to promote discussion and dialogue between the research partners and these organisations. The paper is produced at a time of major changes to approaches to the management of water resources in general and the delivery of WSS services in particular, throughout the developing world. The limitations of traditional approaches based on supply provision have been recognised in many places, and the principles of integrated water resources management developed (IWRM).
    [Show full text]
  • The Implementation of Mass-Vaccination Against SARS-Cov-2: a Systematic Review of Existing Strategies and Guidelines
    Review The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines Tasnim Hasan 1,2, Justin Beardsley 1, Ben J. Marais 3 , Thu Anh Nguyen 2 and Greg J. Fox 1,2,* 1 Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; [email protected] (T.H.); [email protected] (J.B.) 2 The Woolcock Institute of Medical Research, Glebe, NSW 2037, Australia; [email protected] 3 Marie Bahir Institute, The University of Sydney, Westmead, NSW 2145, Australia; [email protected] * Correspondence: [email protected] Abstract: The global drive to vaccinate against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) began in December 2020 with countries in Europe, Middle East, and North America leading the roll out of a mass-vaccination program. This systematic review synthesised all available English-language guidelines and research regarding mass-vaccination for COVID-19 until 1 March 2021—the first three months of the global mass-vaccination effort. Data were extracted from national websites, PubMed, Embase, Medline and medRxiv, including peer and non-peer review research findings. A total of 15 national policy documents were included. Policies were summarised according to the World Health Organisation (WHO) framework for mass vaccination. All included policies prioritised front-line health care workers and the elderly. Limited information was available regarding staffing, cold chain, communication strategies and infrastructure requirements for effective vaccine Citation: Hasan, T.; Beardsley, J.; delivery. A total of 26 research studies were identified, reporting roll-out strategies, vaccine uptake Marais, B.J.; Nguyen, T.A.; Fox, G.J.
    [Show full text]
  • From the Factory to the Frontlines the Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine
    From the Factory to the Frontlines The Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine What This Strategy Aims to Do This report to Congress details a strategy to achieve the principal purpose and objective of Operation Warp Speed (OWS): ensuring that every American who wants to receive a COVID-19 vaccine can receive one, by delivering safe and effective vaccine doses to the American people beginning January 2021. The leadership of OWS has committed to being transparent with Congress, the media, and the American people. OWS has provided regular briefings on topics of interest to Congress and the media and will continue to provide updates and announcements as OWS reaches new milestones. Congress has been a vital partner in the all-of-America response to the COVID-19 pandemic. With support provided through emergency supplemental and flexible discretionary funding, OWS has now made strong progress toward a safe and effective COVID-19 vaccine, with multiple candidates in Phase 3 clinical trials. Simultaneously, OWS and partners are developing a plan for delivering a safe and effective product to Americans as quickly and reliably as possible. Experts from the Department of Health and Human Services (HHS) are leading vaccine development, while experts from the Department of Defense (DoD) are partnering with the Centers for Disease Control and Prevention (CDC) and other parts of HHS to coordinate supply, production, and distribution of vaccines. Successful implementation of the national COVID-19 vaccination program requires precise coordination across federal, state, local, tribal, and territorial governments and among many public and private partners.
    [Show full text]
  • WHO Water, Sanitation and Hygiene Links to Health: Facts and Figures
    Water, Sanitation and Hygiene Links to Health FACTS AND FIGURES - *updated March 2004 "Water and Sanitation is one of the primary drivers of public health. I often refer to it as “Health 101”, which means that once we can secure access to clean water and to adequate sanitation facilities for all people, irrespective of the difference in their living conditions, a huge battle against all kinds of diseases will be won." Dr LEE Jong-wook, Director-General, World Health Organization. Diarrhoea - 1.8 million people die every year from diarrhoeal Intestinal helminths (Ascariasis, Trichuriasis, diseases (including cholera); 90% are children under 5, Hookworm disease) mostly in developing countries. - 133 million people suffer from high intensity - 88% of diarrhoeal disease is attributed to unsafe intestinal helminth infections, which often leads to water supply, inadequate sanitation and hygiene. severe consequences such as cognitive impairment, - Improved water supply reduces diarrhoea morbidity massive dysentery, or anaemia. by 21%. - These diseases cause around 9400 deaths every year. - Improved sanitation reduces diarrhoea morbidity by - Access to safe water and sanitation facilities and 37.5%. better hygiene practice can reduce morbidity from - The simple act of washing hands at critical times can ascariasis by 29% and hookworm by 4%. reduce the number of diarrhoeal cases by up to 35%. - Additional improvement of drinking-water quality, Japanese encephalitis such as point of use disinfection, would lead to a - 20% of clinical cases of Japanese encephalitis die, reduction of diarrhoea episodes of 45%. and 35% suffer permanent brain damage. - Improved management for irrigation of water Malaria resources reduces transmission of disease, in South, - 1.2 million people die of malaria each year, 90% of South East, and East Asia.
    [Show full text]
  • Zambia's Community-Led Total Sanitation Program
    CLA CASE ANALYSIS: DEEP DIVE Zambia’s Community-Led Total Sanitation Program Disclaimer: This report was produced for review by the United States Agency for International Development (USAID). It was prepared by the LEARN mechanism out of the USAID Office of Learning, Evaluation and Research (LER) in the Bureau for Policy, Planning and Learning (PPL). LEARN is managed by Dexis Consulting Group. COVER PHOTO: Zambian girl leaves latrine. (Source: Akros) Photo credit: Andrew Prinsen DEEP DIVE SUMMARY INFORMATION Sector WASH Type of Intervention Community-Led Total Sanitation Program (CLTS), supplemented by a Mobile-to-Web (M2W) application and close collaboration with traditional leaders Country/Region Zambia / Southern Africa Size & Scope Akros, funded by the United Kingdom’s Department for International Development (DFID) and in partnership with UNICEF and the Government of the Republic of Zambia (GRZ), implemented the M2W monitoring component of a Community-Led Total Sanitation (CLTS) program in Zambia as part of the Zambian Sanitation and Health Program (ZSHP), beginning with a few pilot districts, then expanding to all rural counties. Funded Activities In partnership with UNICEF and the Zambian government, Akros developed a Mobile-to-Web (M2W) application using the open-source District Health Information System 2 (DHIS2) software that allowed real-time monitoring of latrine construction and sanitation improvements at the community level across 68 rural districts in Zambia. Akros subsequently also developed a “Chief App,” an Android-based widget that enabled key visualizations to be shared with traditional leaders. The app allowed chiefs and their headmen/women to have access to the data from the wards in their chiefdom as well as the surrounding chiefdoms to help traditional leaders track sanitation progress in their areas.
    [Show full text]
  • Federal Retail Pharmacy Partnership Strategy for COVID-19 Vaccination for General Public Program Summary of Program for Jurisdictions
    December 2, 2020 Federal Retail Pharmacy Partnership Strategy for COVID-19 Vaccination for General Public Program Summary of Program for Jurisdictions The U.S. Department of Health and Human Services and the Centers for Disease Control and Prevention are partnering with pharmacies to increase access to COVID-19 vaccine once one or more vaccines are authorized by the U.S. Food and Drug Administration for use in the United States. There are two federal pharmacy programs: The Pharmacy Partnership for Long-Term Care Program and the Federal Retail Pharmacy Partnership Strategy for COVID-19 Vaccination. Through the Federal Retail Pharmacy Partnership Strategy for COVID-19 Vaccination, retail pharmacy partners can help jurisdictions augment access to vaccine when supply increases and vaccine is recommended beyond the initial populations. With more than 90% of people in the United States living within five miles of a pharmacy, pharmacies have unique reach and ability to provide access to COVID-19 vaccine and support broad vaccination efforts. This program will provide critical vaccination services for the U.S. population, with vaccine administered at store locations at no cost to recipients. The program will be implemented in close coordination with jurisdictions to ensure optimal COVID-19 vaccination coverage and vaccine access nationwide. Program activation will be on a national scale, with select pharmacy partners receiving a direct allocation of COVID- 19 vaccine. Timing and scale of activation (how many partners, how many stores) will depend on various factors, including supply. The federal retail pharmacy program does not include every pharmacy in the United States. Pharmacies not included in the federal program will need to coordinate with their jurisdictions to become COVID- 19 vaccination providers.
    [Show full text]
  • The French Health Care System
    The french health care system The french health care system VICTOR RODWIN PROFESSOR OF HEALTH POLICY AND MANAGEMENT WAGNER SCHOOL OF PUBLIC SERVICE, NEW YORK UNIVERSITY NEW YORK, USA ABSTRACT: The French health care system is a model of national health insurance (NHI) that provides health care coverage to all legal residents. It is an example of public social security and private health care financing, combined with a public-private mix in the provision of health care services. The French health care system reflects three underlying political values: liberalism, pluralism and solidarity. This article provides a brief overview of how French NHI evolved since World War II; its financing health care organization and coverage; and most importantly, its overall performance. ntroduction. Evolution, coverage, financing and organization The French health care system is a model of national health Evolution: French NHI evolved in stages and in response to Iinsurance (NHI) that provides health care coverage to all legal demands for extension of coverage. Following its original passage, residents. It is not an example of socialized medicine, e.g. Cuba. in 1928, the NHI program covered salaried workers in industry and It is not an example of a national health service, as in the United commerce whose wages were under a low ceiling (Galant, 1955). Kingdom, nor is it an instance of a government-run health care In 1945, NHI was extended to all industrial and commercial workers system like the United States Veterans Health Administration. and their families, irrespective of wage levels. The extension of French NHI, in contrast, is an example of public, social security and coverage took the rest of the century to complete.
    [Show full text]
  • 1 PLAYING AGAINST the ROLES SCENE 1 Scene 1
    PLAYING AGAINST THE ROLES SCENE 1 Scene 1. The roof of Daniel and Estrella’s old apartment complex. DANIEL: Estrella! Why did you want to meet here? We’re going to miss the party! ESTRELLA: Can you believe how much this place has changed? DANIEL: I don’t even recognize it. ESTRELLA: It’s all so… white. It used to be filled with smells and sounds and people. DANIEL: Like the sounds of my terrible violin playing. ESTRELLA: I remember the smells that came from those windows. Mi abuela cooking (She pauses and smells the air) mole and fresh tortillas, and elote, and capirotada. DANIEL and ESTRELLA: and that awful Posole. They both make a face. DANIEL: We played for hours. ESTRELLA: With my Barbies. DANIEL: They were rich. ESTRELLA: and they had a swimming pool and like 10 kids and they always fought. DANIEL: Like my mom and dad. Before he left… ESTRELLA: but remember… we would run away and sneak out. DANIEL: And just lay up here and just look at the stars. They sit in silence remembering the past. DANIEL: You know… in a new place, you can be anyone you want. ESTRELLA: Easy for you to say, ”Dannie Beckerman football star.” (She laughs to herself) DANIEL: Speaking of… that party. You promised you’d come. ESTRELLA: I know. Just one more minute. 1 Scene 2 Scene 1. Friday Night. A teenage house party. We hear bumpin music, perhaps something by Drake or Kanye. DANIEL AND ESTRELLA enter the party. There are groups of mostly McGregor High School students scattered about the room laughing and talking loudly.
    [Show full text]
  • Water, Sanitation and Hygiene (WASH)
    July 2018 About Water, Sanitation and UNICEF The United Nations Children’s Fund (UNICEF) Hygiene (WASH) works in more than 190 countries and territories to put children first. UNICEF WASH and Children has helped save more Globally, 2.3 billion people lack access to basic children’s lives than sanitation services and 844 million people lack any other humanitarian organization, by providing access to clean drinking water. The lack of health care and immuni­ these basic necessities isn’t just inconvenient zations, safe water and — it’s lethal. sanitation, nutrition, education, emergency relief Over 800 children die every day — about 1 and more. UNICEF USA supports UNICEF’s work every 2 minutes — from diarrhea due to unsafe through fundraising, drinking water, poor sanitation, or poor advocacy and education in hygiene. Suffering and death from diseases the United States. Together, like pneumonia, trachoma, scabies, skin we are working toward the and eye infections, cholera and dysentery day when no children die from preventable causes could be prevented by scaling up access and every child has a safe to adequate water supply and sanitation and healthy childhood. facilities and eliminating open defecation. For more information, visit unicefusa.org. Ensuring access to water and sanitation in UNICEF has helped schools can also help reduce the number of increase school children who miss out on their education — enrollment in Malawi through the provision especially girls. Scaling up access to WASH of safe drinking water. also supports efforts to protect vulnerable © UNICEF/UN040976/RICH children from violence, exploitation and abuse, since women and girls bear the heaviest Today, UNICEF has WASH programs in 113 burden in water collection, often undertaking countries to promote the survival, protection long, unsafe journeys to collect water.
    [Show full text]
  • Provided By: Techserve Alliance
    Provided by: TechServe Alliance Table of Contents Introduction .............................................................................................. 4 Return-to-Work at a Glance ....................................................................... 5 COVID-19 Return-to-Work Plans ..................................................................................... 5 Other Return-to-Work Considerations ........................................................................... 7 COVID-19 Vaccine Overview ....................................................................... 8 COVID-19 Vaccines and the Workplace ..................................................... 11 Government Guidance Related to COVID-19 Vaccines and Workplaces ...................11 OSHA Perspective ............................................................................... 11 EEOC Perspective ................................................................................ 11 Deciding Between a Mandatory or Voluntary Vaccination Policy ..............................13 General Employer Considerations ..................................................... 13 The Case for Mandatory Workplace Vaccination............................. 14 The Case for Voluntary Workplace Vaccination ............................... 14 Developing a Workplace Vaccination Plan ...................................................................16 Step 1: Gauge the Situation .............................................................. 16 Step 2: Make the Choice ...................................................................
    [Show full text]
  • Would Parents Get Their Children Vaccinated Against SARS-Cov-2? Rate and Predictors of Vaccine Hesitancy According to a Survey Over 5000 Families from Bologna, Italy
    Article Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy Marco Montalti 1,* , Flavia Rallo 1, Federica Guaraldi 2, Lapo Bartoli 3, Giulia Po 4 , Michela Stillo 5, Paola Perrone 5, Lorena Squillace 5, Laura Dallolio 1 , Paolo Pandolfi 5, Davide Resi 5, Maria Pia Fantini 1 , Chiara Reno 1 and Davide Gori 1 1 Unit of Hygiene, Department of Biomedical and Neuromotor Sciences, Public Health and Medical Statistics, University of Bologna, 40126 Bologna, Italy; fl[email protected] (F.R.); [email protected] (L.D.); [email protected] (M.P.F.); [email protected] (C.R.); [email protected] (D.G.) 2 IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy; [email protected] 3 Unit of Primary Health Care, Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy; [email protected] 4 School of Hygiene and Preventive Medicine, University of Ferrara, 44121 Ferrara, Italy; [email protected] 5 Department of Public Health, Bologna Local Health Authority, 40124 Bologna, Italy; [email protected] (M.S.); [email protected] (P.P.); [email protected] (L.S.); paolo.pandolfi@ausl.bologna.it (P.P.); [email protected] (D.R.) * Correspondence: [email protected]; Tel.: +39-051-209-4802 Citation: Montalti, M.; Rallo, F.; Guaraldi, F.; Bartoli, L.; Po, G.; Stillo, Abstract: In the near future, COVID-19 vaccine efficacy trials in larger cohorts may offer the possibility M.; Perrone, P.; Squillace, L.; Dallolio, to implement child and adolescent vaccination.
    [Show full text]
  • Hand Hygiene: Clean Hands for Healthcare Personnel
    Core Concepts for Hand Hygiene: Clean Hands for Healthcare Personnel 1 Presenter Russ Olmsted, MPH, CIC Director, Infection Prevention & Control Trinity Health, Livonia, MI Contributions by Heather M. Gilmartin, NP, PhD, CIC Denver VA Medical Center University of Colorado Laraine Washer, MD University of Michigan Health System 2 Learning Objectives • Outline the importance of effective hand hygiene for protection of healthcare personnel and patients • Describe proper hand hygiene techniques, including when various techniques should be used 3 Why is Hand Hygiene Important? • The microbes that cause healthcare-associated infections (HAIs) can be transmitted on the hands of healthcare personnel • Hand hygiene is one of the MOST important ways to prevent the spread of infection 1 out of every 25 patients has • Too often healthcare personnel do a healthcare-associated not clean their hands infection – In fact, missed opportunities for hand hygiene can be as high as 50% (Chassin MR, Jt Comm J Qual Patient Saf, 2015; Yanke E, Am J Infect Control, 2015; Magill SS, N Engl J Med, 2014) 4 Environmental Surfaces Can Look Clean but… • Bacteria can survive for days on patient care equipment and other surfaces like bed rails, IV pumps, etc. • It is important to use hand hygiene after touching these surfaces and at exit, even if you only touched environmental surfaces Boyce JM, Am J Infect Control, 2002; WHO Guidelines on Hand Hygiene in Health Care, WHO, 2009 5 Hands Make Multidrug-Resistant Organisms (MDROs) and Other Microbes Mobile (Image from CDC, Vital Signs: MMWR, 2016) 6 When Should You Clean Your Hands? 1. Before touching a patient 2.
    [Show full text]